The Protecting Our Children from the CDC Act would amend the Public Health Service Act to bar a COVID-19 vaccine from being added to the child and adolescent immunization schedule until all clinical data in the Department of Health and Human Services’ possession relating to safety and efficacy is posted on the CDC website, with data de-identified. The bill also treats vaccines already on the schedule at enactment as removed and directs the Secretary to take action to remove them, subject to future placement back on the schedule if subsection (a) is satisfied and other laws permit.
The definition of the schedule is anchored to the ACIP schedule or its successor. The goal is transparency and explicit data access before scheduling decisions, rather than post hoc acceptance based on internal reviews alone.
At a Glance
What It Does
It adds a requirement that no COVID-19 vaccine be placed on the child/adolescent immunization schedule until the DHHS posting of all relevant clinical data on safety and efficacy on the CDC site, with data de-identified.
Who It Affects
Affects HHS agencies (notably CDC and ACIP), the Secretary, vaccine manufacturers, pediatric health providers, immunization program staff, and families who rely on the schedule.
Why It Matters
Sets a hard data-posting condition for scheduling, creating a transparency standard that could influence stakeholder trust and future decision-making around pediatric immunizations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill shifts the trigger for adding a COVID-19 vaccine to the child and adolescent schedule from internal assessments to an explicit data transparency requirement. Before the Secretary can place a vaccine on the schedule, all clinical data in DHHS relevant to safety and efficacy must be posted on the CDC’s public website, and the data must be de-identified.
This provision expands the public availability of trial and observational data tied to vaccine safety and performance, including adverse effects. The text also states that any vaccine already on the schedule as of enactment is deemed removed, and the Secretary must act to remove it, while preserving the possibility of reinsertion later if the data posting condition is met and other legal requirements are satisfied.
The definition of the schedule ties directly to the ACIP’s schedule or any successor. The overarching aim is to couple immunization policy with explicit data accessibility rather than relying solely on internal reviews.
The Five Things You Need to Know
The bill requires posting of all DHHS clinical data on COVID vaccines before any addition to the child/adolescent schedule.
Data posted must be de-identified to protect privacy and health information.
Vaccines already on the schedule at enactment are deemed removed, triggering administrative removal actions.
The Secretary may reinsert a vaccine only if data posting requirements are met and applicable law is followed.
The bill defines the relevant schedule as the ACIP schedule or its successor.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This Act may be cited as the Protecting Our Children from the CDC Act. It establishes the statutory branding and branding consistency for the bill and signals the focus on data transparency in pediatric immunization decisions.
No inclusion of COVID vaccines without posted data
The Secretary and any DHHS office (including the CDC and ACIP) may not include any COVID-19 vaccine on the child and adolescent immunization schedule unless all clinical data in DHHS possession relating to safety and efficacy is posted on the CDC public website. The data posted must cover safety, efficacy, and adverse effects and must be de-identified to protect personal health information and information about agency personnel involved in the data.
Removal of vaccines on schedule as of enactment
Any COVID-19 vaccine that is included on the child and adolescent immunization schedule as of the date of enactment is deemed to be removed from the schedule. This creates an immediate administrative effect that requires action to remove the vaccine from the schedule.
Administrative action to effect removal
The Secretary shall take such actions as may be necessary to effectuate removal of a vaccine from the schedule by operation of subsection (b)(1). This places a concrete mandate on federal agencies to implement the schedule change.
Rule of construction
The removal of a vaccine from the schedule under subsection (b)(1) does not preclude placing the vaccine back on the schedule later, so long as such placement complies with subsection (a) and other applicable law.
Definitions
Defines the term ‘child and adolescent immunization schedule’ as the ACIP schedule (or any successor). This anchors the bill’s scope to the standard pediatric immunization framework used by public health authorities.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Parents and guardians seeking full data to inform consent and discussions with pediatricians
- Pediatricians and family medicine practitioners who counsel families and interpret safety/efficacy data
- Independent researchers and data-transparency advocates who require access to primary data for analysis
- State and local immunization program staff who administer schedules and communicating policy changes
- Public health and patient-safety advocacy groups that push for transparent data around vaccine safety
Who Bears the Cost
- The Department of Health and Human Services, CDC, and ACIP will bear additional data-publishing obligations and potential operational costs
- Vaccine manufacturers may face heightened scrutiny and potential reputational or market impacts from broader data visibility
- State and local health departments may incur administrative burdens reconciling schedule changes with state laws and registries
- Healthcare providers may experience increased demand for counseling and clarification amid schedule changes
- Health insurers and provider networks could face administrative costs as schedules shift and data interpretation evolves
Key Issues
The Core Tension
The central dilemma is transparency versus timeliness and flexibility. Requiring full DHHS data posting before scheduling increases public access and accountability, but it may delay updates to the immunization schedule in ways that limit rapid responses to evolving evidence or public health needs. Balancing the desire for open data with pragmatic scheduling and risk-benefit assessment is the bill’s core policy tension.
The bill’s transparency premise is straightforward, but its implementation raises practical questions. Requiring all clinical DHHS data to be posted publicly will demand substantial data curation, redaction, and ongoing maintenance to ensure accuracy and timeliness.
While data must be de-identified, there is a risk of residual identifiability or misinterpretation of complex safety data by non-experts. The bill does not specify standards for data format, completeness, or peer review, raising questions about data quality and how stakeholders should weigh conflicting findings.
The administrative burden on the CDC, ACIP, and related offices could be nontrivial, potentially slowing schedule updates even when data support rapid decision-making. These considerations will shape how the policy translates into practice and how quickly immunization schedules can respond to new evidence.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.